NCT01744756已完成2 期
Interventional Trial of Subconjunctival Bevacizumab in Recurrent Pterygium
Instituto de Olhos de Goiania1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2012年2月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- Pterygium size after subconjunctival bevacizumab
研究概览
简要总结
A study to research whether subconjunctival bevacizumab injection may potentially suppress neovascularization in pterygium, retarding and decreasing the size of recurrent pterygium.
详细描述
- Pacients with recurrent pterygium
- Anti-VEGF therapy -Bevacizumab
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Recurrent pterygium
排除标准
- •Pregnant or lactating women
- •History of myocardial infarction
- •History of stroke
研究组 & 干预措施
Subconjunctival Bevacizumab
Experimental
One aplication of subconjunctival Bevacizumab 0,5 ml
干预措施: Bevacizumab (Drug)
结局指标
主要结局
Pterygium size after subconjunctival bevacizumab
时间窗: 8 weeks
-Size of recurrent pterygium (measured in mm) after injection
次要结局
- Number of Participants with Adverse Events as a Measure of Safety and Tolerability(8 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent PterygiumPterygium of the Conjunctiva and CorneaNCT01288404Ramathibodi Hospital80
Unknown
2 期
Bevacizumab for the Treatment of Corneal NeovascularizationCorneal NeovascularizationNCT00992849Chang Gung Memorial Hospital10
已完成
不适用
Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to TrabeculectomyComplications of TreatmentProgressionNCT01425112Sudhalkar Eye Hospital180
已完成
2 期
Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal NeovascularizationCorneal NeovascularizationNCT00555594Asociación para Evitar la Ceguera en México18
已完成
4 期
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic RetinopathyProliferative Diabetic RetinopathyDiabetic Traction Retinal DetachmentVitreous HemorrhageNCT01854593Nihon University69